The company is demonstrably advanced this course of the innovative treatment for amyloid heart disease, utilizing the compound. Preliminary patient data indicates promising benefits for patients diagnosed by this https://biotech429026.ivasdesign.com/63304521/bridgebio-advances-cardiac-amyloidosis-treatment-through-the-drug